Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

LON/0RNS stock hub

LON/0RNS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0RNSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.6M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0RNS

In the news

Latest news · LON/0RNS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-74

P25 n/aP50 n/aP75 n/a

ROIC-5,189.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0RNS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

154

Groups with data

Currency

AUD

Showing 154 of 154 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	3
Employees Change	-9%
Employees Change Percent	-75
Enterprise value	EUR -527,237
Exchange	London Stock Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 3.6M
Price	EUR 8.91
Price currency	EUR
Rev Per Employee	32,102.67x
Sic	2834
Symbol	lon/0RNS
Website	https://www.rnplc.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-42.34%
EV Earnings	0.34x
EV/FCF	0.34x
FCF yield	-42.65%
P/B ratio	0.86x
P/S ratio	37.7x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	27.24%
Gross Profit	EUR 26,231
Gross Profit Growth	-89.02%
Gross Profit Growth3 Y	-70.74%
Gross Profit Growth5 Y	-53.97%
Net Income	EUR -1.5M
Pretax Margin	-1,596.11%
Profit Per Employee	EUR -512,393
ROA	-32.85
Roa5y	-130.8
ROCE	-30.63
ROE	-74.03
ROIC	-5,189.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	122.85%
Cagr3y	-81.3%
Revenue Growth	-78.81x
Revenue Growth Q	-87.33x
Revenue Growth3 Y	-59.64x
Revenue Growth5 Y	-45.67x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.04
Assets	EUR 4.5M
Cash	EUR 4.2M
Current Assets	EUR 4.8M
Current Liabilities	EUR 256,714
Debt	EUR 38,590
Debt Equity	EUR 0.01
Debt FCF	EUR -0.02
Equity	EUR 4.2M
Liabilities	EUR 272,413
Long Term Assets	EUR -297,845
Long Term Liabilities	EUR 15,699
Net Cash	EUR 4.2M
Net Cash By Market Cap	EUR 116
Net Cash Growth	370,708.93%
Net Debt Equity	EUR -0.99
Tangible Book Value	EUR 4.2M
Tangible Book Value Per Share	EUR 0.01
WACC	2.83

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	18.68
Inventory Turnover	0.4
Net Working Capital	EUR -4,018
Quick ratio	17.72
Working Capital	EUR 4.2M
Working Capital Turnover	EUR 0.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-866.14%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	122.73%
200-day SMA	5.5
3Y total return	-99.35%
50-day SMA	5.42
50-day SMA vs 200-day SMA	50under200
All Time High	324,000
All Time High Change	-100%
All Time High Date	2022-02-17
All Time Low	2.4
All Time Low Change	308.33%
All Time Low Date	2025-11-24
ATR	1.01
Beta	-0.25
Ch YTD	276.9
High	9.1
High52	22.4
High52 Date	2025-06-06
High52ch	-60.22%
Low	8.91
Low52	2.4
Low52 Date	2025-11-24
Low52ch	271.25%
Ma50ch	80.98%
Price vs 200-day SMA	78.28%
RSI	54.21
RSI Monthly	29.87
RSI Weekly	49.61
Sharpe ratio	0.53x
Sortino ratio	2.11
Total Return	-866.14%
Tr YTD	276.9
Tr1m	-7.89%
Tr1w	9.99%
Tr3m	-16.67%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -1.3M
Operating margin	-1,353.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Net Borrowing	1,453,874.8
Shares Qo Q	0%
Shares Yo Y	866.14%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -1.5M
Average Volume	138.95x
Bv Per Share	0.01
CAPEX	EUR -766
Ch1m	-7.89
Ch1w	9.99
Ch1y	122.7
Ch3m	-16.67
Ch3y	-99.35
Ch6m	206.3
Change	0%
Change From Open	-2.09
Depreciation Amortization	12,158
Dollar Volume	3,742.2
Earnings Date	2026-06-26
EBIT	EUR -1.3M
EBITDA	EUR -1.3M
EPS	EUR -0
F Score	2
FCF	EUR -1.5M
FCF EV Yield	293.72x
Financing CF	5,741,570
Fiscal Year End	December
Founded	2,001
Investing CF	-766
Is Primary Listing	0
Last Earnings Date	2025-12-24
Last Report Date	2025-12-31
Last Split Date	2026-01-23
Last Split Type	Reverse
Ma150	5.12
Ma150ch	91.52%
Ma20	8.12
Ma20ch	20.66%
Net CF	4,190,298
Next Earnings Date	2026-06-26
Open	9.1
Position In Range	0
Ppne	31,223.5
Price Date	2026-05-08
Ptbv Ratio	0.86
Relative Volume	3.02x
Revenue	96,308x
Tr6m	206.25%
Volume	420
Z Score	1.43

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0RNS pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0RNS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0RNS?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+866.1%

Negative means the company is buying back shares.

Technical

LON/0RNS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

54.2

Neutral momentum band

Price vs 200-day MA

+78.3%

50/200-day relationship not available

Beta (5Y)

-0.25

Less volatile than the market

Sharpe ratio

0.53

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0RNS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0RNS stock rating?

lon/0RNS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0RNS analysis?

The full report lives at /stocks/lon/0RNS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0RNS?

The latest report frames lon/0RNS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0RNS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.